نتائج البحث - K. Serhal

  • يعرض 1 - 1 نتائج من 1
تنقيح النتائج
  1. 1
    189O A phase II study of patritumab deruxtecan (HER3-DXd), in patients (pts) with advanced breast cancer (ABC), with biomarker analysis to characterize response to therapy (ICARUS-BREAST01)

    189O A phase II study of patritumab deruxtecan (HER3-DXd), in patients (pts) with advanced breast cancer (ABC), with biomarker analysis to characterize response to therapy (ICARUS-... حسب B. Pistilli, Nusaïbah Ibrahimi, M. Lacroix-Triki, Véronique D’Hondt, Cécile Vicier, Jean‐Sébastien Frénel, Florence Dalenc, Thomas Bachelot, M-A. Benderra, Delphine Loirat, Agnès Ducoulombier, Didier Mayeur, Ghada Nachabeh, K. Serhal, Noémie Corcos, Dalila Sellami, Stefan Michiels, Fabrice André, M.F. Mosele, Guillaume Montagnac

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: